AMTI Applied Molecular Transport Inc.

Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases.

$14.87  -1.22 (-7.58%)
As of 12/03/2021 15:59:50 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/05/2020
Outstanding shares:  38,489,589
Average volume:  236,955
Market cap:   $619,297,487
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03824M109
ISIN:        US03824M1099
Sedol:      BMFYGD5
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.04
PS ratio:   0.00
Return on equity:   -47.55%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy